Compare BridgeBio Pharma Inc (BBIO) vs EOG Resources Inc (EOG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs EOG Resources Inc — how do they compare? BridgeBio Pharma Inc trades at $84.9 (market cap $16.46B), while EOG Resources Inc trades at $138.97 (market cap $73.51B). The key difference: EOG Resources Inc is far larger — about 4.5× BridgeBio Pharma Inc's market cap, and EOG Resources Inc pays a 2.96% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | EOG | |
|---|---|---|
Market Cap | $16.46B | $73.51B |
Sector | Health | Energy |
52-Week High | $90.17 | $149.89 |
52-Week Low | $44.81 | $101.78 |
Enterprise Value | $18.02B | $77.97B |
Dividend Yield | — | 2.96% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EOG Resources trades at $139.61, up 4.11% with a bullish technical outlook. The stock shows strong profitability with a net margin of 23.39% and ROE of 18.19%, supported by consistent earnings beats. Valuation ratios like P/E of 13.73 and EV/EBITDA of 6.6 appear attractive relative to historical levels. Recent news highlights operational excellence and dividend stability, with Q2 2026 earnings anticipated on August 5, 2026.
The outlook remains positive with a consensus price target of $156.40, implying 12% upside. Risks include oil price volatility and elevated capital expenditures, but EOG's low-cost production and solid balance sheet provide resilience. Analyst sentiment is strongly bullish with no sell ratings, reinforcing the investment case for growth and income.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →
